CXCR3 and autoimmune disease: CXCR3 antagonists were initially proposed for the treatment of inflammatory and autoimmune diseases; however, recent studies suggest that they may have therapeutic potential in a broader spectrum of diseases (Wijtmans et al., 2014; Wijtmans et al., 2011; Wijtmans et al., 2008).